Executive Wealth Management, LLC Eli Lilly & CO Transaction History

Executive Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $891,261 - $1.19 Million	1,505 Added 36.69%	5,607 $4.36 Million
Q4 2023 Jan 26, 2024	BUY	$525.19 - $619.13 $2.15 Million - $2.54 Million	4,102 New	4,102 $2.39 Million
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $16,125 - $17,540	-151 Reduced 9.93%	1,370 $153,000
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $52,514 - $61,297	474 Added 45.27%	1,521 $168,000
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $96,283 - $113,332	-865 Reduced 45.24%	1,047 $136,000
Q4 2018 Feb 19, 2019	BUY	$105.9 - $118.64 $202,480 - $226,839	1,912 New	1,912 $221,000

3,869

751M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Executive Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Executive Wealth Management, LLC with notifications on news.